It was announced by Chantilly, Va.-based Vencore, Inc. that it will be collaborating with Havas Health to expand the marketing of Vencore Health’s patient finder technology to pharmaceutical companies. This technology is used to help identify patients with difficult to diagnose diseases.
Donna Murphy, Chief Executive Officer at Havas Health stated, “Pharmaceutical companies invest heavily in developing drugs that can treat and even cure rare diseases. The proven patient finder technology that Vencore offers can enhance our clients’ abilities to efficiently and effectively connect their treatments with potential patients.”
By applying proven analytical methods and advanced machine learning algorithms to unidentified patient data Vencore Health Analytics is able to identify many different hard-to-diagnose diseases in patients. In turn, with the help of this information patients are able to seek treatments and cures they would otherwise not be aware they were in need of.
Mac Curtis, President and Chief Executive Officer at Vencore said, “The Vencore-Havas Health collaboration is an exceptional partnership, bringing together best-of-breed data analytics expertise with unparalleled marketing experience and leadership. This new relationship will allow Vencore to expand its reach and make a life-changing, and in some cases life-saving, impact on patients who suffer from ailments that have gone undiagnosed for years.”
Related: DARPA Awards $3.7 Million Contract to Vencore
